Showing results (131-140 of 852) with videos related to
Sort By:
Pageof 86
Leukemia & Lymphoma|July 26, 2021
Disease heterogeneity, prognostication and the role of targeted therapy in multiple myelomaSaurabh Zanwar, Shaji KumarLeukemia & Lymphoma|January 12, 2018
PI3K/AKT/mTOR pathway in multiple myeloma: from basic biology to clinical promiseVijay Ramakrishnan, Shaji KumarLeukemia & Lymphoma|December 22, 2024
Risk-adapted treatment for multiple myeloma: assessing the current potential and a roadmap for the futureSaurabh Zanwar, Shaji KumarJournal of the American Society of Nephrology : JASN|April 23, 2011
Early reduction of serum-free light chains associates with renal recovery in myeloma kidneyColin A Hutchison, Paul Cockwell, Stephanie Stringer, et al.Blood|October 24, 2002
Prognostic value of angiogenesis in solitary bone plasmacytomaShaji Kumar, Rafael Fonseca, Angela Dispenzieri, et al.American Journal of Hematology|June 1, 2010
Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndromeTrista Stankowski-Drengler, Morie A Gertz, Jerry A Katzmann, et al.Blood|May 25, 2010
Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complicationsGiada Bianchi, Robert A Kyle, Colin L Colby, et al.Blood Cancer Journal|February 10, 2021
Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee ReportDavid L Murray, Noemi Puig, Sigurdur Kristinsson, et al.Seminars in Oncology|April 30, 2003
Angiogenesis in Waldenstrom's macroglobulinemiaS Vincent Rajkumar, Suzanne Hayman, Philip R GreippJournal of the American Society of Nephrology : JASN|April 29, 2018
The Complexity and Heterogeneity of Monoclonal Immunoglobulin-Associated Renal DiseasesSanjeev Sethi, S Vincent Rajkumar, Vivette D D'AgatiPageof 86